Observational study on hypertrophic cardiomyopathy in Chinese patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on hypertrophic cardiomyopathy (HCM), a common inherited cardiac condition, by recruiting patients to collect comprehensive clinical data and biological specimens. It aims to explore the genetic and molecular underpinnings of HCM through multi-omics screening, which includes genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Additionally, the study will evaluate the effectiveness of existing sudden cardiac death risk stratification guidelines in the Chinese population and identify novel risk factors and predictive models tailored for these patients.

Why it matters

Who can join: the full rules

Inclusion criteria: Patients with HCM diagnosed by observation of unexplained maximal left ventricle wall thickness ≥15 mm on echocardiography and/or cardiac magnetic resonance imaging or or ≥13 mm for individuals with family history of HCM.

Exclusion criteria: Individuals with other cardiac or systemic diseases capable of producing that magnitude of cardiac hypertrophy.

Where it's running

• Fuwai hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Principal investigator: Song Lei, MD.&ph.D — Chinese Academy of Medical Sciences, Fuwai Hospital
• Study coordinator: Song Lei, MD.&ph.D
• Email: clinicalfw@163.com
• Phone: 86-13810532620

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mavacamten plus supervised exercise for people with obstructive hypertrophic cardiomyopathy

  This trial tests whether supervised moderate endurance and resistance training is safe and improves fitness for adults with obstructive hypertrophic cardiomyopathy who have been on stable mavacamten treatment.

  Recruiting Technical University of Munich · Munich, Bavaria · NCT07077005

• Registry for hereditary cardiovascular diseases in Brazil

  This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.

  Recruiting at 27 sites Hospital do Coracao · Rio Branco, Acre and 26 other locations · NCT06546137

• Identifying cardiac amyloidosis in older adults with lumbar spinal stenosis

  This study is trying to find out if older adults who have had surgery for lumbar spinal stenosis also have a heart condition called transthyretin cardiac amyloidosis by looking at their spinal tissue and using advanced technology.

  Recruiting at 5 sites Columbia University · Beverly Hills, California and 5 other locations · NCT06034405

• Comparing hybrid and catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

  This study is testing whether a new hybrid ablation method works better than traditional catheter ablation for controlling heart rhythm in patients with hypertrophic cardiomyopathy and ongoing atrial fibrillation.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT05610215

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.